Yeah. I reckon Pharmorage might follow a similar route to Nyrada, and take their new pipeline drugs to an IPO. Personally I like this approach, with NOX holding a big chunk.
But for Veyonda and COVID, should it prove viable? Whatever the quickest route, which I guess is partner and licensing to whoever can run with it.
- Forums
- ASX - By Stock
- NOX
- Ann: NOXCOVID Program to Expand After Positive Phase 1 Results
Ann: NOXCOVID Program to Expand After Positive Phase 1 Results, page-36
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.60M |
Open | High | Low | Value | Volume |
11.0¢ | 12.0¢ | 10.5¢ | $84.79K | 771.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 179890 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.5¢ | 349534 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 179890 | 0.100 |
1 | 25357 | 0.098 |
2 | 176978 | 0.096 |
1 | 35000 | 0.094 |
1 | 20000 | 0.093 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 349534 | 1 |
0.125 | 128094 | 1 |
0.130 | 239671 | 4 |
0.135 | 499760 | 2 |
0.140 | 790213 | 10 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |